Dysregulation of key microRNAs in pancreatic cancer development
- PMID: 30551350
- DOI: 10.1016/j.biopha.2018.10.177
Dysregulation of key microRNAs in pancreatic cancer development
Abstract
Pancreatic cancer (PC) is mentioned as one of the fourth major cause of cancer-related deaths and also is considered as one of the most malignancies worldwide. Sadly, widely metastasis is frequently observed at the time of PC detection and there are, thereby, almost poor prognosis and ineffective treatment in PC patients. microRNAs (miRNAs), a group of short non-coding RNAs, regulate various cellular and developmental mechanisms, such as cell growth, proliferation, apoptosis, differentiation and angiogenesis. Also, they have essential roles even on the progression of different human and animal diseases. In recent years, extensive studies confirmed the important role of miRNAs in various steps of PC developments, including; tumor initiation, invasion and metastasis, which can use valuably for cancer detection, prognosis and therapy. Therefore, the present study reviewed the new recent investigations in miRNAs involvement in the biology of PC associated with their clinical implications.
Keywords: Biomarker; Diagnosis; Dysregulation; MicroRNA; Pancreatic cancer.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.
Similar articles
-
LncRNAs in pancreatic cancer.Oncotarget. 2016 Aug 30;7(35):57379-57390. doi: 10.18632/oncotarget.10545. Oncotarget. 2016. PMID: 27429196 Free PMC article. Review.
-
Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.Adv Drug Deliv Rev. 2015 Jan;81:16-33. doi: 10.1016/j.addr.2014.10.020. Epub 2014 Oct 23. Adv Drug Deliv Rev. 2015. PMID: 25453266 Free PMC article. Review.
-
Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.Adv Exp Med Biol. 2015;889:71-87. doi: 10.1007/978-3-319-23730-5_5. Adv Exp Med Biol. 2015. PMID: 26658997 Free PMC article.
-
miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer.Mol Cancer. 2017 Oct 27;16(1):167. doi: 10.1186/s12943-017-0723-7. Mol Cancer. 2017. PMID: 29078789 Free PMC article.
-
Clinical value of circular RNAs and autophagy-related miRNAs in the diagnosis and treatment of pancreatic cancer.Hepatobiliary Pancreat Dis Int. 2019 Dec;18(6):511-516. doi: 10.1016/j.hbpd.2019.09.009. Epub 2019 Sep 28. Hepatobiliary Pancreat Dis Int. 2019. PMID: 31610988 Review.
Cited by
-
An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma.Biosensors (Basel). 2022 Oct 6;12(10):831. doi: 10.3390/bios12100831. Biosensors (Basel). 2022. PMID: 36290970 Free PMC article.
-
ROS-Responsive Polymeric Micelles for Triggered Simultaneous Delivery of PLK1 Inhibitor/miR-34a and Effective Synergistic Therapy in Pancreatic Cancer.ACS Appl Mater Interfaces. 2019 Apr 24;11(16):14647-14659. doi: 10.1021/acsami.9b02756. Epub 2019 Apr 12. ACS Appl Mater Interfaces. 2019. PMID: 30933478 Free PMC article.
-
Microbiome and MicroRNA or Long Non-Coding RNA-Two Modern Approaches to Understanding Pancreatic Ductal Adenocarcinoma.J Clin Med. 2023 Aug 30;12(17):5643. doi: 10.3390/jcm12175643. J Clin Med. 2023. PMID: 37685710 Free PMC article. Review.
-
MicroRNAs in pancreatic cancer drug resistance: mechanisms and therapeutic potential.Front Cell Dev Biol. 2025 Jan 15;12:1499111. doi: 10.3389/fcell.2024.1499111. eCollection 2024. Front Cell Dev Biol. 2025. PMID: 39882259 Free PMC article. Review.
-
Apigenin Targets MicroRNA-155, Enhances SHIP-1 Expression, and Augments Anti-Tumor Responses in Pancreatic Cancer.Cancers (Basel). 2022 Jul 25;14(15):3613. doi: 10.3390/cancers14153613. Cancers (Basel). 2022. PMID: 35892872 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical